과제정보
This work was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korea government (MSIT) (NRF-2023R1A2C2007632) and the Research Fund, 2021 of The Catholic University of Korea.
참고문헌
- Shen Y, Li CG, Zhou SF, Pang EC, Story DF, Xue CC (2008) Chemistry and bioactivity of Flos Magnoliae, a Chinese herb for rhinitis and sinusitis. Curr Med Chem 15:1616-1627. https://doi.org/10.2174/092986708784911515
- Hong PTL, Kim HJ, Kim WK, Nam JH (2021) Flos magnoliae constituent fargesin has an anti-allergic effect via ORAI1 channel inhibition. Korean J Physiol Pharmacol 25:251-258. https://doi.org/10.4196/kjpp.2021.25.3.251
- Baek JA, Lee YD, Lee CB, Go HK, Kim JP, Seo JJ, Rhee YK, Kim AM, Na DJ (2009) Extracts of Magnoliae flos inhibit inducible nitric oxide synthase via ERK in human respiratory epithelial cells. Nitric Oxide 20:122-128. https://doi.org/10.1016/j.niox.2008.10.003
- Kim JS, Kim JY, Lee HJ, Lim HJ, Lee DY, Kim DH, Ryu JH (2010) Suppression of inducible nitric oxide synthase expression by furfuran lignans from flower buds of Magnolia fargesii in BV-2 microglial cells. Phytother Res 24:748-753. https://doi.org/10.1002/ptr.3028
- Pham TH, Kim MS, Le MQ, Song YS, Bak Y, Ryu HW, Oh SR, Yoon DY (2017) Fargesin exerts anti-inflammatory effects in THP-1 monocytes by suppressing PKC-dependent AP-1 and NF-ĸB signaling. Phytomedicine 24:96-103. https://doi.org/10.1016/j.phymed.2016.11.014
- Yue B, Ren YJ, Zhang JJ, Luo XP, Yu ZL, Ren GY, Sun AN, Deng C, Wang ZT, Dou W (2018) Anti-inflammatory effects of fargesin on chemically induced inflammatory bowel disease in mice. Molecules 23:1380. https://doi.org/10.3390/molecules23061380
- Lu J, Zhang H, Pan J, Hu Z, Liu L, Liu Y, Yu X, Bai X, Cai D, Zhang H (2021) Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-ĸB pathways. Arthritis Res Ther 23:142. https://doi.org/10.1186/s13075-021-02512-z
- Jun AY, Kim HJ, Park KK, Son KH, Lee DH, Woo MH, Chung WY (2014) Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. Invest New Drugs 32:1-13. https://doi.org/10.1007/s10637-013-9969-0
- Wang G, Gao J, He LH, Yu XH, Zhao ZW, Zou J, Wen FJ, Zhou L, Wan XJ, Tang CK (2020) Fargesin alleviates atherosclerosis by promoting reverse cholesterol transport and reducing inflammatory response. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158633. https://doi.org/10.1016/j.bbalip.2020.158633
- Wang X, Cheng Y, Xue H, Yue Y, Zhang W, Li X (2015) Fargesin as a potential β1 adrenergic receptor antagonist protects the hearts against ischemia/reperfusion injury in rats via attenuating oxidative stress and apoptosis. Fitoterapia 105:16-25. https://doi.org/10.1016/j.ftote.2015.05.016
- Sha S, Xu D, Wang Y, Zhao W, Li X (2016) Antihypertensive effects of fargesin in vitro and in vivo via attenuating oxidative stress and promoting nitric oxide release. Can J Physiol Pharmacol 94:900-906. https://doi.org/10.1139/cjpp-2015-0615
- Lee YS, Cha BY, Choi SS, Harada Y, Choi BK, Yonezawa T, Teruya T, Nagai K, Woo JT (2012) Fargesin improves lipid and glucose metabolism in 3T3-L1 adipocytes and high-fat dietinduced obese mice. BioFactors 38:300-308. https://doi.org/10.1002/biof.1022
- Choi SS, Cha BY, Choi BK, Lee YS, Yonezawa T, Teruya T, Nagai K, Woo JT (2013) Fargesin, a component of Flos Magnoliae, stimulates glucose uptake in L6 myotubes. J Nat Med 67:320-326. https://doi.org/10.1007/s11418-012-0685-4
- Lee GE, Lee CJ, An HJ, Kang HC, Lee HS, Lee JY, Oh SR, Cho SJ, Kim DJ, Cho YY (2021) Fargesin inhibits EGF-induced cell transformation and colon cancer cell growth by suppression of CDK2/Cyclin E signaling pathway. Int J Mol Sci 22:2073. https://doi.org/10.3390/ijms22042073
- Fu T, Chai B, Shi Y, Dang Y, Ye X (2019) Fargesin inhibits melanin synthesis in murine malignant and immortalized melanocytes by regulating PKA/CREB and P38/MAPK signaling pathways. J Dermatol Sci 94:213-219. https://doi.org/10.1016/j.jdermsci.2019.03.004
- Foti RS, Dalvie DK (2016) Cytochrome P450 and noncytochrome P450 oxidative metabolism: contributions to the pharmacokinetics, safety, and efficacy of xenobiotics. Drug Metab Dispos 44:1229-1245. https://doi.org/10.1124/dmd.116.071753
- Hwang DK, Kim JH, Shin Y, Choi WG, Kim S, Cho YY, Lee JY, Kang HC, Lee HS (2019) Identification of catalposide metabolites in human liver and intestinal preparations and characterization of the relevant sulfotransferase, UDP-glucuronosyltransferase, and carboxylesterase enzymes. Pharmaceutics 11:355. https://doi.org/10.3390/pharmaceutics11070355
- Lee MS, Lim CH, Bang YY, Lee HS (2022) Quantification of fargesin in mouse plasma using liquid chromatography-high resolution mass spectrometry: application to pharmacokinetics of fargesin in mice. Mass Spectro Lett 13:20-25. https://doi.org/10.5478/MSL.2022.13.1.20
- Zhang Z, Liu X, Cao W, Xiao X, Qu J, Zhao M, Li X (2016) Pharmacokinetics and tissue distribution of fargesin after oral administration in rats by high performance liquid chromatography. Curr Pharm Anal 12:379. https://doi.org/10.2174/1573412912666151211191600
- Kim JH, Kwon SS, Jeong H, Lee HS (2017) Inhibitory effects of dimethyllirioresinol, epimagnolin A, eudesmin, fargesin, and magnolin on cytochrome P450 enzyme activities in human liver microsomes. Int J Mol Sci 18:952. https://doi.org/10.3390/ijms18050952
- Park R, Park EJ, Cho YY, Lee JY, Kang HC, Song IS, Lee HS (2021) Tetrahydrofurofuranoid lignans, eudesmin, fargesin, epimagnolin A, magnolin, and yangambin inhibit UDP-glucuronosyltransferase 1A1 and 1A3 activities in human liver microsomes. Pharmaceutics 13:187. https://doi.org/10.3390/pharmaceutics13020187
- Kim JH, Kim DK, Choi WG, Ji HY, Choi JS, Song IS, Lee S, Lee HS (2020) In vitro metabolism of DWP16001, a novel sodium-glucose cotransporter 2 inhibitor, in human and animal hepatocytes. Pharmaceutics 12:865. https://doi.org/10.3390/pharmaceutics12090865
- Davies B, Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095. https://doi.org/10.1023/a:1018943613122
- Kong TY, Kim JH, Choi WG, Lee JY, Kim HS, Kim JY, In MK, Lee HS (2017) Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes. Anal Bioanal Chem 409:1667-1680. https://doi.org/10.1007/s00216-016-0113-9
- Lee HS, Jeong TC, Kim JH (1998) In vitro and in vivo metabolism of myristicin in the rat. J Chromatogr B Biomed Sci Appl 705:367-372. https://doi.org/10.1016/s0378-4347(97)00531-8
- Yun CH, Lee HS, Lee HY, Yim SK, Kim KH, Kim E, Yea SS, Guengerich FP (2003) Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin. Toxicol Lett 137:143-150. https://doi.org/10.1016/s0378-4274(02)00397-1
- Yang AH, He X, Chen JX, He LN, Jin CH, Wang LL, Zhang FL, An LJ (2015) Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2. Chem Biol Interact 237:133-140. https://doi.org/10.1016/j.cbi.2015.06.018
- Zhang X, Qiao GX, Zhao GF, Zhao SF (2021) Characterization of the metabolites of irisforentin by using ultra-high performance liquid chromatography combined with quadrupole/orbitrap tandem mass spectrometry. J Pharm Biomed Anal 203:114222. https://doi.org/10.1016/j.jpba.2021.114222
- Yasuda K, Ikushiro S, Kamakura M, Ohta M, Sakaki T (2010) Metabolism of sesamin by cytochrome P450 in human liver microsomes. Drug Metab Dispos 38:2117-2123. https://doi.org/10.1124/dmd.110.035659
- Yasuda K, Ikushiro S, Kamakura M, Munetsuna E, Ohta M, Sakaki T (2011) Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver. Drug Metab Dispos 39:1538-1545. https://doi.org/10.1124/dmd.111.039875
- Yasuda K, Sakaki T (2012) How is sesamin metabolised in the human liver to show its biological effects? Expert Opin Drug Metab Toxicol 8:93-102. https://doi.org/10.1517/17425255.2012.637917
- Li Y, Li M, Wang Z, Wen M, Tang J (2020) Identification of the metabolites of piperine via hepatocyte incubation and liquid chromatography combined with diode-array detection and highresolution mass spectrometry. Rapid Commun Mass Spectrom 34:e8947. https://doi.org/10.1002/rcm.8947
- Cheng C, Zhao S, Gu YL, Pang J, Zhao Y (2022) Characterization and identification of the metabolites of dihydromethysticin by ultra-high-performance liquid chromatography orbitrap highresolution mass spectrometry. J Sep Sci 45:2914-2923. https://doi.org/10.1002/jssc.202200250
- Chen X, Li Y (2021) Identification of the stable and reactive metabolites of tetrahydropiperine using ultrahigh-performance liquid chromatography combined with diode-array detection and high-resolution mass spectrometry. Rapid Commun Mass Spectrom 35:e8975. https://doi.org/10.1002/rcm.8975
- Xie Q, Chen Y, Liu F, Zhong Z, Zhao K, Ling Z, Wang F, Tang X, Wang Z, Liu L, Liu X (2016) Interspecies differences in metabolism of deoxypodophyllotoxin in hepatic microsomes from human, monkey, rat, mouse and dog. Drug Metab Pharmacokinet 31:314-322. https://doi.org/10.1016/j.dmpk.2016.05.002
- Sun D, Gao X, Wang Q, Krausz KW, Fang Z, Zhang Y, Xie C, Gonzalez FJ (2021) Metabolic map of the antiviral drug podophyllotoxin provides insights into hepatotoxicity. Xenobiotica 51:1047-1059. https://doi.org/10.1080/00498254.2021.1961920
- Simonneaux G, Le Maux P (2006) Carbene complexes of heme proteins and iron porphyrin models. Top Organomet Chem 17:83-122. https://doi.org/10.1007/3418_006
- Kim DK, Liu K-H, Jeong JH, Ji HY, Oh SR, Lee H-K, Lee HS (2011) In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes. Xenobiotica 41:358-371. https://doi.org/10.3109/00498254.2010.549968
- Xia Y, Pang H, Dou T, Wang P, Ge G (2018) Interspecies comparison in the COMT-mediated methylation of 3-BTD. RSC Adv 8:16278-16284. https://doi.org/10.1039/c8ra01938j
- Jalkanen A, Lassheikki V, Torsti T, Gharib E, Lehtonen M, Juvonen RO (2021) Tissue and interspecies comparison of catechol-O-methyltransferase mediated catalysis of 6-O-methylation of esculetin to scopoletin and its inhibition by entacapone and tolcapone. Xenobiotica 51:268-278. https://doi.org/10.1080/00498254.2020.1853850